Table 3.
A. Multiple sclerosis patients | |||||
---|---|---|---|---|---|
SERUM | hhv6b-miR-Ro6-2 | hhv6b-miR-Ro6-3-5p | CSF | hhv6b-miR-Ro6-2 | hhv6b-miR-Ro6-3-5p |
hhv6b-miR-Ro6-3-5p |
r = 0.823 p = 7.4E-11 pcorr = 2.22E-10 n = 40 |
hhv6b-miR-Ro6-3-5p |
r = 0.529 p = 0.024 n = 18 |
||
miR-U86 |
r = 0.434 p = 0.039 pcorr = 0.117 n = 23 |
r = 0.627 p = 0.001 pcorr = 0.003 n = 23 |
miR-U86 | n/a n = 4 |
n/a n = 1 |
B. Other neurological diseases patients | |||||
Serum | hhv6b-miR-Ro6-2 | hhv6b-miR-Ro6-3-5p | CSF | hhv6b-miR-Ro6-2 | hhv6b-miR-Ro6-3-5p |
hhv6b-miR-Ro6-3-5p |
r = 0.857 p = 7E-7 pcorr = 2.1E-6 n = 21 |
hhv6b-miR-Ro6-3-5p |
r = 0.764 p = 0.006 n = 11 |
||
miR-U86 |
r = 0.770 p = 0.006 pcorr = 0.018 n = 11 |
r = 0.793 p = 0.004 pcorr = 0.012 n = 11 |
miR-U86 | n/a n = 2 |
n/a n = 1 |
N, number of subjects; N/a, not applicable; r, Spearman's rank correlation coefficient; pcorr, Bonferroni-corrected p-value.